Literature DB >> 20425608

Neurologic complications of cancer and its treatment.

Pierre Giglio1, Mark R Gilbert.   

Abstract

The central nervous system (CNS) and peripheral nervous system (PNS) are very susceptible to cancer and its treatment. The most direct involvement of the nervous system manifests in the development of primary brain and spinal cord tumors. Many cancers exhibit a propensity toward spread to the CNS, and brain metastases are common problems seen in malignancies such as lung, breast, and melanoma. Such spread may involve the brain or spine parenchyma or the subarachnoid space. In the PNS, spread is usually through direct infiltration of nerve roots, plexi, or muscle by neighboring malignancies. In some cases, cancer has sudden, devastating effects on the nervous system: epidural spinal cord compression or cord transection from pathologic fractures of vertebra involved by cancer; increased intracranial pressure from intracranial mass lesion growth and edema; and uncontrolled seizure activity as a result of intracranial tumors (status epilepticus), which are neuro-oncologic emergencies. The best known indirect or remote effects of cancer on the nervous system are the neurologic paraneoplastic syndromes. Cancer can also result in a hypercoagulable state causing cerebrovascular complications. Treatment of cancer can have neurologic complications. The commonest of these complications are radiation-induced injury to the brain, spine, and peripheral nerves and chemotherapy-induced peripheral neuropathy. The suppressant effect of cancer and its treatment on the body's immune system can result in infectious complications within the nervous system.

Entities:  

Mesh:

Year:  2010        PMID: 20425608      PMCID: PMC3637950          DOI: 10.1007/s11912-009-0071-x

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  49 in total

1.  Radiation-induced brachial plexopathy: MR and clinical findings.

Authors:  B C Bowen; A Verma; A H Brandon; J A Fiedler
Journal:  AJNR Am J Neuroradiol       Date:  1996 Nov-Dec       Impact factor: 3.825

2.  A comparison of polymerase chain reaction examination of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis.

Authors:  C H Rhodes; M J Glantz; L Glantz; A Lekos; G D Sorenson; C Honsinger; N B Levy
Journal:  Cancer       Date:  1996-02-01       Impact factor: 6.860

3.  Carcinomatous meningitis.

Authors:  M C Chamberlain
Journal:  Arch Neurol       Date:  1997-01

4.  Radiation-induced brachial plexopathy: MR imaging.

Authors:  H Wouter van Es; A M Engelen; T D Witkamp; L M Ramos; M A Feldberg
Journal:  Skeletal Radiol       Date:  1997-05       Impact factor: 2.199

5.  The natural history of lumbosacral plexopathy in cancer.

Authors:  K A Jaeckle; D F Young; K M Foley
Journal:  Neurology       Date:  1985-01       Impact factor: 9.910

6.  Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials.

Authors:  L Gaspar; C Scott; M Rotman; S Asbell; T Phillips; T Wasserman; W G McKenna; R Byhardt
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-03-01       Impact factor: 7.038

7.  Radiation-induced dementia in patients cured of brain metastases.

Authors:  L M DeAngelis; J Y Delattre; J B Posner
Journal:  Neurology       Date:  1989-06       Impact factor: 9.910

8.  Distribution of brain metastases.

Authors:  J Y Delattre; G Krol; H T Thaler; J B Posner
Journal:  Arch Neurol       Date:  1988-07

9.  Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid-flow status.

Authors:  M J Glantz; W A Hall; B F Cole; B S Chozick; C M Shannon; L Wahlberg; W Akerley; L Marin; H Choy
Journal:  Cancer       Date:  1995-06-15       Impact factor: 6.860

10.  Cerebrovascular complications in patients with cancer.

Authors:  F Graus; L R Rogers; J B Posner
Journal:  Medicine (Baltimore)       Date:  1985-01       Impact factor: 1.889

View more
  24 in total

1.  Is chronic postsurgical pain surgery-induced? A study of persistent postoperative pain following breast reconstruction.

Authors:  Randy S Roth; Ji Qi; Jennifer B Hamill; Hyungjin M Kim; Tiffany N S Ballard; Andrea L Pusic; Edwin G Wilkins
Journal:  Breast       Date:  2017-11-13       Impact factor: 4.380

Review 2.  Cancer-treatment-induced neurotoxicity--focus on newer treatments.

Authors:  Jacqueline B Stone; Lisa M DeAngelis
Journal:  Nat Rev Clin Oncol       Date:  2015-09-22       Impact factor: 66.675

Review 3.  A Focused Review of Safety Considerations in Cancer Rehabilitation.

Authors:  Susan Maltser; Adrian Cristian; Julie K Silver; G Stephen Morris; Nicole L Stout
Journal:  PM R       Date:  2017-09       Impact factor: 2.298

4.  A quantitative sensory analysis of peripheral neuropathy in colorectal cancer and its exacerbation by oxaliplatin chemotherapy.

Authors:  Mariana de Carvalho Barbosa; Alyssa K Kosturakis; Cathy Eng; Gwen Wendelschafer-Crabb; William R Kennedy; Donald A Simone; Xin S Wang; Charles S Cleeland; Patrick M Dougherty
Journal:  Cancer Res       Date:  2014-09-02       Impact factor: 12.701

5.  Subclinical peripheral neuropathy is a common finding in colorectal cancer patients prior to chemotherapy.

Authors:  Jessica A Boyette-Davis; Cathy Eng; Xin S Wang; Charles S Cleeland; Gwen Wendelschafer-Crabb; William R Kennedy; Donald A Simone; Haijun Zhang; Patrick M Dougherty
Journal:  Clin Cancer Res       Date:  2012-04-10       Impact factor: 12.531

6.  Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy.

Authors:  Richard A Morgan; Nachimuthu Chinnasamy; Daniel Abate-Daga; Alena Gros; Paul F Robbins; Zhili Zheng; Mark E Dudley; Steven A Feldman; James C Yang; Richard M Sherry; Giao Q Phan; Marybeth S Hughes; Udai S Kammula; Akemi D Miller; Crystal J Hessman; Ashley A Stewart; Nicholas P Restifo; Martha M Quezado; Meghna Alimchandani; Avi Z Rosenberg; Avindra Nath; Tongguang Wang; Bibiana Bielekova; Simone C Wuest; Nirmala Akula; Francis J McMahon; Susanne Wilde; Barbara Mosetter; Dolores J Schendel; Carolyn M Laurencot; Steven A Rosenberg
Journal:  J Immunother       Date:  2013-02       Impact factor: 4.456

7.  The clinical and pathological features of 133 colorectal cancer patients with brain metastasis: a multicenter retrospective analysis of the Gastrointestinal Tumors Working Committee of the Turkish Oncology Group (TOG).

Authors:  Ozgur Tanriverdi; Esra Kaytan-Saglam; Sukran Ulger; Ibrahim Vedat Bayoglu; Ibrahim Turker; Turkan Ozturk-Topcu; Suna Cokmert; Serdar Turhal; Esin Oktay; Bulent Karabulut; Diclehan Kilic; Yuksel Kucukzeybek; Berna Oksuzoglu; Nezih Meydan; Vildan Kaya; Tulay Akman; Kamuran Ibis; Mert Saynak; Cenk Ahmet Sen; Ozlem Uysal-Sonmez; Kezban Nur Pilancı; Gokhan Demir; Sezer Saglam; Muharrem Kocar; Serkan Menekse; Gamze Goksel; Burcu Yapar-Taskoylu; Arzu Yaren; Ummugul Uyeturk; Nilufer Avci; Bengu Denizli; Esra Ilis-Temiz
Journal:  Med Oncol       Date:  2014-08-10       Impact factor: 3.064

8.  Prechemotherapy Touch Sensation Deficits Predict Oxaliplatin-Induced Neuropathy in Patients with Colorectal Cancer.

Authors:  Xin Shelley Wang; Qiuling Shi; Patrick M Dougherty; Cathy Eng; Tito R Mendoza; Loretta A Williams; David R Fogelman; Charles S Cleeland
Journal:  Oncology       Date:  2016-02-17       Impact factor: 2.935

9.  Blockade of Kv1.3 channels ameliorates radiation-induced brain injury.

Authors:  Ying Peng; Kui Lu; Zichen Li; Yaodong Zhao; Yiping Wang; Bin Hu; Pengfei Xu; Xiaolei Shi; Bin Zhou; Michael Pennington; K George Chandy; Yamei Tang
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

10.  Examination of blood-brain barrier (BBB) integrity in a mouse brain tumor model.

Authors:  Ngoc H On; Ryan Mitchell; Sanjot D Savant; Corbin J Bachmeier; Grant M Hatch; Donald W Miller
Journal:  J Neurooncol       Date:  2012-11-27       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.